Subclinical macroangiopathic target organ damage in type 1 diabetes mellitus patients
Authors:
- 28 May 2020
- journal article
- review article
- Published by Taylor & Francis in Blood Pressure
- Vol. 29 (6) , 344-356
Abstract
Purpose: We have summarized key studies regarding the assessment of subclinical macroangiopathic target organ damage (TOD) in type 1 diabetes mellitus (T1DM). Results: Although chronic complications resulting from hyperglycemia, in particular macroangiopathies, are still the first cause of death in T1DM, there has been growing recognition of the role of hypoglycemia in cardiovascular morbidity and mortality. Subclinical TOD diagnosis ensures early implementation of the complex management aiming at either partial reversal of these complications or at least its downturn. To better identify patients with early TODs, several non-invasive diagnostic techniques are employed, including the ultrasonographic assessment of the intima-media thickness (IMT), computed tomography (CT) for coronary artery calcium (CAC) scores, and pulse wave velocity (PWV) measurement for arterial stiffness evaluation. Various studies reported that T1DM patients present an increased IMT. An increasing IMT fairly correlates with the cardiovascular (CV) events risk even after the adjustment to age, diabetes duration, quality of glucose control as well as the presence of hypertension, and chronic complications. Another, well established marker of the organ damage – CAC score is recommended by ACC/AHA guidelines to assess the overall CV risk in T1DM. Also, the arterial stiffness evaluation with PWV may further improve CV risk prediction, which has been reported in multiple studies including the Framingham Heart Study. Conclusions: There is shortage of data from prospective studies which could confirm the benefits of early treatment initiation based on the presence of the subclinical organ damage in T1DM. Most evidence comes from T2DM trials, where effective preventive measures were identified i.e.: smoking cessation, reasonable blood glucose control, efficacious hypertension treatment, and dyslipidemia management, as well as renoprotection. There is still a field for further research to see if routine assessment of asymptomatic vascular damage and early implementation of aggressive treatment would reduce mortality excess from CVD in T1DM.Keywords
This publication has 93 references indexed in Scilit:
- Relationship between vascular stiffness and stress myocardial perfusion imaging in asymptomatic patients with diabetesEuropean Journal of Nuclear Medicine and Molecular Imaging, 2011
- Reduced Heart Rate Variability Predicts Progression of Coronary Artery Calcification in Adults with Type 1 Diabetes and Controls Without DiabetesDiabetes Technology & Therapeutics, 2010
- Pulse wave analysis and prevalent cardiovascular disease in type 1 diabetesAtherosclerosis, 2010
- Glycaemic variability is associated with coronary artery calcium in men with Type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes studyDiabetic Medicine, 2010
- Lipoprotein-associated phospholipase A2 and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studiesThe Lancet, 2010
- Arterial Stiffness and Cardiovascular EventsCirculation, 2010
- Reactive Oxygen Species Enhance Insulin SensitivityCell Metabolism, 2009
- Is glycaemia or insulin dose the stronger risk factor for coronary artery disease in type 1 diabetes?Diabetes & Vascular Disease Research, 2009
- A1C Variability Predicts Incident Cardiovascular Events, Microalbuminuria, and Overt Diabetic Nephropathy in Patients With Type 1 DiabetesDiabetes, 2009
- Reactive oxygen species have a causal role in multiple forms of insulin resistanceNature, 2006